Drug
Ft538
Ft538: highest development phase Phase 1, developed by Fate Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Fate Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| FT538 NCT04614636 | Phase 1 | Acute Myeloid Leukemia |
| FT538 NCT05069935 | Phase 1 | Solid Tumor, Adult |
Latest
No recent events.
Follow Ft538 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.